| 376.93 5.87 (1.58%) | 01-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 447.34 | 1-year : | 522.49 |
| Resists | First : | 383 | Second : | 447.34 |
| Pivot price | 372.1 |
|||
| Supports | First : | 354.9 | Second : | 337.54 |
| MAs | MA(5) : | 371.43 |
MA(20) : | 366.67 |
| MA(100) : | 338.64 |
MA(250) : | 361.14  |
|
| MACD | MACD : | 7.5 |
Signal : | 8.1 |
| %K %D | K(14,3) : | 73.4 |
D(3) : | 69 |
| RSI | RSI(14): 62.2 |
|||
| 52-week | High : | 458.75 | Low : | 273.7 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ELV ] has closed below upper band by 22.2%. Bollinger Bands are 52% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 378.72 - 380.51 | 380.51 - 382.2 |
| Low: | 363.28 - 365.35 | 365.35 - 367.29 |
| Close: | 373.53 - 376.78 | 376.78 - 379.84 |
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Tue, 27 Jan 2026
Vanguard Personalized Indexing Management LLC Has $9.58 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Tue, 27 Jan 2026
CIBC Asset Management Inc Has $11.01 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
Tue, 27 Jan 2026
Barlow Wealth Partners Inc. Trims Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Mon, 26 Jan 2026
What To Expect From Elevance Health's (ELV) Q4 Earnings - Finviz
Mon, 26 Jan 2026
Whittier Trust Co. of Nevada Inc. Sells 31,380 Shares of Elevance Health, Inc. $ELV - MarketBeat
Mon, 26 Jan 2026
Elevance Health, Inc. $ELV Shares Sold by Whittier Trust Co. - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 222 (M) |
| Shares Float | 222 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 92 (%) |
| Shares Short | 4,100 (K) |
| Shares Short P.Month | 3,880 (K) |
| EPS | 24.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 197.94 |
| Profit Margin | 2.8 % |
| Operating Margin | 3.4 % |
| Return on Assets (ttm) | 4.2 % |
| Return on Equity (ttm) | 12.5 % |
| Qtrly Rev. Growth | 12.3 % |
| Gross Profit (p.s.) | 230.2 |
| Sales Per Share | 876.61 |
| EBITDA (p.s.) | 40.13 |
| Qtrly Earnings Growth | 22 % |
| Operating Cash Flow | 4,910 (M) |
| Levered Free Cash Flow | 5,120 (M) |
| PE Ratio | 15.35 |
| PEG Ratio | 0 |
| Price to Book value | 1.9 |
| Price to Sales | 0.42 |
| Price to Cash Flow | 17.06 |
| Dividend | 1.71 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|